<DOC>
	<DOCNO>NCT01257048</DOCNO>
	<brief_summary>The main purpose study evaluate sensitivity new oxygen enhance magnetic resonance imaging ( OE-MRI ) method detect change lung patient moderate severe chronic obstructive pulmonary disease ( COPD ) follow treatment either Oxis Turbuhaler Symbicort Turbuhaler .</brief_summary>
	<brief_title>Evaluation Oxygen Enhanced Magnetic Resonance Imaging Method Patients With Chronic Obstructive Pulmonary Disease During 8 Weeks Treatment With Either Symbicort Turbuhaler Oxis Turbuhaler</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Budesonide , Formoterol Fumarate Drug Combination</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<criteria>Age great equal 40 year Male female Clinical diagnosis moderate severe COPD accord GOLD guideline Current ex smoker smoke history equivalent least 20 cigarette smoke per day 10 year A Modified Medical Research Council ( MMRC ) dyspnoea scale score â‰¥2 . FEV1/FVC &lt; 0.7 ( postbronchodilator ) FEV1 &gt; 40 % PN &lt; 70 % PN ( postbronchodilator ) Clinical Study Protocol Local Amendment affect UK : FEV1 &gt; 30 % PN &lt; 80 % PN ( postbronchodilator ) Current diagnosis asthma accord GINA guideline Pregnancy , breastfeed plan pregnancy study . Fertile woman use acceptable contraceptive measure judge investigator Significant upper low respiratory tract infection fully recover 4 week prior visit 1 Participation schedule intensive COPD rehabilitation program Claustrophobia , pacemaker , clip within brain , previous brain heart surgery , history metal eye MRI contraindication obesity inability stay supine position 60 minute</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Oxygen enhance magnetic resonance imaging</keyword>
	<keyword>chronic obstructive pulmonary disease</keyword>
	<keyword>method evaluation</keyword>
</DOC>